You just read:

Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases

News provided by

Janssen Pharmaceutical Companies of Johnson & Johnson

Jan 31, 2019, 06:30 ET